Cardiovascular Diseases

Fish Oil and Vitamin D Supplementation Not Beneficial

A nationwide, randomized, placebo-controlled trial revealed that daily supplementation with high-dose vitamin D or n-3 fatty acids for 5 years among initially healthy adults in the US did not reduce the incidence of cancer or the incidence of major cardiovascular events. The trial included 25,871 participants (5106 black, ages >/=50 years for men and >/=55 years for women). Marine n−3 (i.e. omega-3) fatty acids were supplemented at a dose of 1 g per day and vitamin D3 (cholecalciferol) was supplemented at a dose of 2000 IU per day. During a median follow-up of 5.3 years, cancer was diagnosed in 793 participants in the vitamin D group and 824 in the placebo group; hazard ratio (HR), 0.96. A major cardiovascular event occurred in 396 participants in the vitamin D group and 409 in the placebo group; HR, 0.97. A major cardiovascular event occurred in 386 participants in the n−3 group and in 419 in the placebo group; HR, 0.92 (HR for total myocardial infarction, 0.72 in the analyses of key secondary end points). Invasive cancer was diagnosed in 820 participants in the n−3 group and in 797 in the placebo group; HR, 1.03. No excess risks of bleeding, hypercalcemia or other serious adverse events were observed. The disappointing findings filled some knowledge gaps in a diverse U.S. cohort. Source: https://www.nejm.org/

hyangiu

Recent Posts

Lifestyle Intervention May Slow Early Cerebral Small-Vessel Injury

A secondary MRI analysis of the US POINTER randomized clinical trial found that a structured…

15 hours ago

Shared and Region-Specific Dementia Risk Factors

Dementia risk factors vary substantially across countries, but they frequently cluster together in similar patterns…

21 hours ago

Comparative Benefits and Risks of Anti-Obesity Drugs

A systematic review and network meta-analysis of 262 randomized trials involving 99,791 participants found that…

4 days ago

Early Mild Hypertrophic Cardiomyopathy May Still Carry Significant Cardiovascular Risk

Approximately 21% of patients with phenotypically mild hypertrophic cardiomyopathy (HCM) experienced major adverse cardiovascular events…

6 days ago

High-Intensity Interval Exercise Reduces Energy Intake in Adults With Overweight or Obesity

A Danish randomized crossover trial found that a single session of high-intensity interval exercise (HIIE)…

7 days ago

Proton Pump Inhibitor and Antibiotic Use May Reduce the Benefit of Immunotherapy in NSCLC

Baseline use of proton pump inhibitors (PPIs) and, to a lesser extent, antibiotics was associated…

1 week ago

This website uses cookies.